Nike, Alpine Immune Sciences rise premarket; CarMax, Robinhood and Regeneron fall

Investing.com -- U.S. futures slipped lower Thursday, adding to the previous session’s losses ahead of the release of another key inflation report.

Here are some of the biggest premarket U.S. stock movers today:

• 
  

  Nike (NYSE: NKE) stock rose 1.4% after the sportswear giant unveiled its Olympic kits, betting that top athletes can help it win more everyday consumers.

  
  


• 
  

  Alpine Immune Sciences (NASDAQ: ALPN) stock rose over 36% after Vertex Pharmaceuticals (NASDAQ: VRTX) said it would buy the biotech for about $4.9 billion in cash, gaining access to its treatment for an autoimmune disease of the kidney.

  
  


• 
  

  CarMax (NYSE: KMX) stock fell 9.1% after the used vehicle retailer posted a lower fourth-quarter profit, hurt by decreased profitability from units sold.

  
  


• 
  

  Amazon (NASDAQ: AMZN) stock fell 0.4% after the online retail giant’s CEO, Andy Jassy, said the e-commerce firm is still seeking opportunity to reduce costs in its fulfillment network, after trimming staff in a number of divisions over the recent months.

  
  


• 
  

  Robinhood (NASDAQ: HOOD) stock fell 3.6% after Citigroup downgraded the brokerage to ‘sell’ from ‘neutral’, citing its correlation with Bitcoin, despite improving fundamentals.

  
  


• 
  

  Regeneron (NASDAQ: REGN) stock fell 1% after the drugmaker was accused of fraudulent practices by the Justice Department, related to its vision drug, Eylea.

  
  


• 
  

  Rent the Runway (NASDAQ: RENT) stock rose 30% after the clothing rental subscription service posted a narrower loss than a year ago, showing modest subscriber retention.

  
  


• 
  

  Fastenal (NASDAQ: FAST) stock fell 5.6% after the industrial distributor reported disappointing first-quarter earnings, with CEO Dan Florness saying that ”the core issue remains poor demand.”

  
  


• 
  

  Albemarle (NYSE: ALB) stock rose 1.1% after Berenberg upgraded its stance on the lithium miner to ‘buy’ from ‘hold’, citing a rise in lithium volumes and an upward trend in lithium prices, negating the need for it to seek additional equity financing in the near future.

  
  

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• This digital health stock is ready to re-rate higher: Goldman
• Credo Technology pops 3.5% as Evercore initiates with monster $325 price target